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Abstract
Asthma is a heterogeneous disease with varying severity and subtypes. Recent reviews of 
epidemiologic studies have identified cleaning and disinfecting activities (CDAs) as important risk 
factors for asthma-related outcomes among healthcare workers. However, the complexity of CDAs 
in healthcare settings has rarely been examined. This study utilized a complex survey dataset and 
data reduction approaches to identify and group healthcare workers with similar patterns of asthma 
symptoms, and then explored their associations with groups of participants with similar patterns of 
CDAs. Self-reported information on asthma symptoms/care, CDAs, demographics, smoking 
status, allergic status, and other characteristics were collected from 2030 healthcare workers 
within nine selected occupations in New York City. Hierarchical clustering was conducted to 
systematically group participants based on similarity of patterns of the 27 asthma symptom/care 
variables, and 14 product applications during CDAs, separately. Word clouds were used to 
visualize the complex information on the resulting clusters. The associations of asthma health 
clusters (HCs) with exposure clusters (ECs) were evaluated using multinomial logistic regression. 
Five HCs were identified (HC-1 to HC-5), labelled based on predominant features as: “no 
symptoms”, “winter cough/phlegm”, “mild asthma symptoms”, “undiagnosed/untreated asthma”, 
and “asthma attacks/exacerbations”. For CDAs, five ECs were identified (EC-1 to EC-5), labelled 
as: “no products”, “housekeeping/chlorine”, “patient care”, “general cleaning/laboratory”, and 
“disinfection products”. Using HC-1 and EC-1 as the reference groups, EC-2 was associated with 
HC-4 (odds ratio (OR)=3.11, 95% confidence interval (95% CI)=1.46–6.63) and HC-5 (OR=2.71, 
95% CI=1.25–5.86). EC-3 was associated with HC-5 (OR=2.34, 95% CI=1.16–4.72). EC-4 was 
associated with HC-5 (OR=2.35, 95% CI=1.07–5.13). EC-5 was associated with HC-3 (OR=1.81, 
95% CI=1.09–2.99) and HC-4 (OR=3.42, 95% CI=1.24–9.39). Various combinations of product 
applications like using alcohols, bleach, high-level disinfectants, and enzymes to disinfect 
instruments and clean surfaces captured by the ECs were identified as risk factors for the different 
asthma symptoms clusters, indicating that prevention efforts may require targeting multiple 
products. The associations of HCs with EC can be used to better inform prevention strategies and 
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treatment options to avoid disease progression. This study demonstrated hierarchical clustering 
and word clouds were useful techniques for analyzing and visualizing a complex dataset with a 
large number of potentially correlated variables to generate practical information that can inform 
prevention activities.
Keywords
Asthma symptoms; Cleaning and disinfecting activities; Hierarchical cluster analysis; Healthcare 
workers
1. Introduction
Work-related asthma (WRA) subsumes occupational asthma and work-exacerbated asthma, 
and is a common but preventable respiratory disease occurring in the workplace (Friedman-
Jimenez et al., 2015; Tarlo et al., 2008). In 2016, WRA affected as many as 2.7 million U.S. 
workers, especially healthcare workers who had among the highest prevalence of current and 
lifetime asthma (10.7–12.4%) (Dodd and Mazurek, 2016; Mazurek and Weissman, 2016; 
Wiszniewska and Walusiak-Skorupa, 2014). Asthma is a heterogeneous disease 
characterized by chronic airway inflammation, with variable airflow limitation and 
symptoms such as wheeze, chest tightness, frequent cough, and shortness of breath (SOB) 
(Global Initiative for Asthma, 2018).
Asthma comprises multiple subtypes characterized by distinct underlying 
pathophysiological mechanisms sharing common observable characteristics (phenotypes) 
(Bradding and Green, 2010). The type of data used for asthma phenotypical classification 
schemes can include respiratory symptoms, sensitizer vs. irritant causative agents, and 
eosinophilic vs. neutrophilic responses to causative agents (Bradding and Green, 2010). In 
addition, some schemes are based on data-driven approaches such as principal components 
analysis, clustering, and machine learning applied to health-related information (Deliu et al., 
2016; Howard et al., 2015). In occupational epidemiologic studies, asthma is often defined 
as a dichotomous outcome based on a series of questions on symptoms, asthma medication 
use and physician diagnosis (Pekkanen et al., 2005). However, given the heterogeneity of 
asthma, asthma likely occurs on a continuous spectrum with varying degrees of severity, 
phenotypes, and subtypes (Deliu et al., 2016; Pekkanen et al., 2005). Approaches to better 
characterize this heterogeneity in asthma include using grouping methods, for example 
hierarchical clustering to identify asthma subtypes or combining multiple symptoms to 
generate an asthma severity score (Deliu et al., 2016; Sunyer et al., 2007). Numerous studies 
have identified asthma subtypes via grouping asthma symptoms, physiologic function and 
biomonitoring results, but occupational epidemiologic studies have generally not evaluated 
the associations between these asthma subtypes and workplace exposures.
Several recent reviews of epidemiologic studies have identified cleaning and disinfecting 
activities (CDAs) as important risk factors for asthma-related outcomes among healthcare 
workers (Folletti et al., 2017; Mazurek and Weissman, 2016; Wiszniewska and Walusiak-
Skorupa, 2014; Zock et al., 2010). However, the complexity of CDAs and the exposures they 
generate in healthcare settings has rarely been examined. A recent population-based study in 
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France used clustering methods to characterize the pattern of cleaning product use in 
domestic settings (Marbac et al., 2018). However, CDAs and the resulting exposures are 
typically evaluated in epidemiologic models as single exposure variables, with the exception 
of one study (Arif et al., 2009) that evaluated the effects of grouped cleaning and 
disinfecting products on WRA. To better represent the reality of mixed exposures in the 
workplace, the current study utilizes a complex survey dataset and systematic data reduction 
approaches to characterize the patterns of CDAs among healthcare workers. The objective of 
the study was to identify clusters of healthcare workers with similar asthma symptom 
patterns that may represent different underlying asthma subtypes or severity, and to explore 
their associations with groups of participants with similar patterns of CDAs and exposures. 
Understanding the associations of these clusters with workplace exposures can better inform 
prevention strategies and treatment options.
2. Materials and methods
2.1. Study population and data collection
This study was reviewed and approved by the NIOSH Institutional Review Board and 
informed consent was obtained before participation. During 2014, healthcare workers who 
were members of the Service Employees International Union Local 1199 who worked in 
hospitals or nursing homes in New York City received a letter of invitation, information 
about the study and consent form, followed by telephone calls to administer the interviewer-
led questionnaire and several subsequent reminders. A total of 2030 participants from nine 
selected occupations completed a telephone or web-based questionnaire, and represented 
13.3% of the effective sample size (i.e., invitees known or presumed to be eligible), and 
22.5% of the 9009 with whom we had at least some telephone contact; a majority of those 
who did not complete the questionnaire were never reached by telephone. The nine selected 
occupations were central supply workers, dental assistants, environmental service workers or 
housekeepers, medical or clinical laboratory technicians, licensed practical nurses, nursing 
assistants, operating room technicians, registered nurses, and respiratory therapists or 
technicians. Inverse probability weights were calculated to address any potential selection or 
non-participation bias using models that addressed differences between participants vs non-
participants and the sample frame, in terms of the distribution of age, gender, occupation, 
smoking status, and wheeze in the last 12 months, as described in detail by Caridi et al. 
(2019). The survey questionnaire was developed based on standardized instruments (Burney 
et al., 1994; Ferris, 1978; Jarvis, 2002; Sunyer et al., 2007) and a previous healthcare study 
(Delclos et al., 2006, 2007). The survey was designed to collect data on demographics (e.g., 
age, gender, race, education), smoking status (i.e., never, former, or current smoker), 
physician-diagnosed and last 12-months asthma symptoms (e.g., wheeze, SOB, coughing, 
phlegm or mucous production, asthma attack, treatment and medication use for asthma), 
CDAs (e.g., frequency and duration of tasks and product-use, tools, controls), medical 
history (e.g., allergic status), last 5-year employment history (e.g., industry, job title), and 
home environment (e.g., water damage, mold growth, renovations, cleaning activities). The 
survey questionnaire was presented in English and Spanish by trained interviewers on the 
telephone and in English online.
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2.2. Data analyses
2.2.1. Respiratory health variables—The main health outcomes in the current study 
were 27 variables for asthma symptoms/care occurring in the last 12-months (Table 1). 
Majority of asthma symptoms/care variables were indicator variables (present/absent), 
except for number of asthma attacks, number of missed workdays because of asthma, and 
number of urgent treatments for asthma, which had three categories. Four composite health 
outcomes were created using variables collected in the survey questionnaire, including 
asthma score, bronchial hyper-responsiveness (BHR)-related symptoms, allergic status, and 
physician-diagnosed asthma. An asthma score was calculated as the sum of the positive 
responses to the following questions on symptoms in the last 12 months (yes=1, no=0; 
scores ranged from 0 to 5): breathless when wheezing, woken up with tightness in chest, 
daytime SOB at rest, SOB following strenuous activity, and woken by SOB. The asthma 
score was developed and validated by the European Community Respiratory Health Survey 
researchers as a measure of asthma severity (Sunyer et al., 2007). BHR-related symptoms 
were assessed via an algorithm that yielded a dichotomous outcome based on eight 
symptoms: trouble with breathing; attack or episode of SOB in the last 12 months; wheezing 
or whistling in the chest in the last 12 months; woken by an attack of cough in the last 12 
months; woken by an attack of chest tightness in the last 12 months; itchy or watery eyes 
when near animals, feathers, or in a dusty part of the house; feeling of chest tightness when 
near animals, feathers, or in a dusty part of the house; and itchy or watery eyes when near 
flowers or pollen (Delclos et al., 2006, 2007). Allergic status was defined as a positive 
response to any of the following criteria: ever had nasal or sinus allergies (e.g., hay fever), 
ever had eczema or any kind of skin allergy, ever had allergies to animals, ever had allergies 
to dust or dust mites, or ever had allergies to latex. Physician-diagnosed asthma was defined 
as a positive response to all of the following criteria: ever had asthma, ever had an episode of 
asthma symptoms, and asthma confirmed by a physician (Caridi et al., 2019). Information 
on other respiratory diseases, such as previous diagnoses of chronic obstructive pulmonary 
disease (COPD) and emphysema, was also drawn from participants’ self-reported medical 
histories.
2.2.2. Cleaning and disinfecting activity variables—Information on CDAs in the 
last 12 months was collected using six modules in the survey questionnaire: 1. Tasks and 
products used in sterilizing medical instruments; 2. Tasks and products used during cleaning 
fixed surfaces, equipment or instruments; 3. Combined task/product use while working in a 
medical or clinical laboratory; 4. Tasks and products used on patients such as chemicals, 
adhesives, antiseptics, alcohols or solvents; 5. Combined task/product use while 
administering aerosolized medications; and 6. Combined task/product use while working as 
a dental assistant; all modules included information on the frequency and duration of tasks 
and product use. These six modules had more than 250 variables, and the current study 
mainly used indicator variables (0 versus 1) and ordinal frequency scores (0: no use, 1/low: 
use 1–3 days per week, and 2/high: use 4–7 days per week) of tasks and product-use for 
statistical analyses. In addition, we grouped the raw indicator variables into 14 cleaning and 
disinfecting product application variables which were used in exposure clustering including: 
high-level disinfectants, alcohols, chlorine bleach, enzymes, formaldehyde, detergents, floor 
wax stripper, glass cleaners, phenolics, quaternary ammonium compounds (quats), skin-
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wipes used on patients, clinical or medical laboratory products, aerosolized medications, and 
dental products (Table 2). These 14 cleaning and disinfecting product application variables 
were combinations of tasks and product-use (e.g., variable chlorine bleach was defined as: 
use of chlorine bleach to clean and disinfect fixed-surface, equipment or instruments). This 
grouping approach enabled the assignment of total VOC (TVOC) exposures to participants 
who performed these 14 product application tasks based on our previous exposure study 
described below (Su et al., 2018).
2.2.3. Frequency-weighted total volatile organic compound (TVOC) 
exposures—In a previous study, we modeled the associations between TVOC exposures 
and the 14 CDAs using personal exposure measurements and observations of CDAs 
collected from 100 healthcare workers at four hospitals that were not part of the present 
study (Su et al., 2018). Two measures of the TVOC exposures were used as the outcome 
variable in the predictive models which included indicator variables (1/0) of the 14 CDAs as 
predictors: 1) the sum of 14 VOCs (ethanol, acetone, 2-propanol, methylene chloride, 
hexane, chloroform, benzene, methyl-methacrylate, toluene, ethylbenzene, m,p-xylene, o-
xylene, α-pinene, and d-limonene), and 2) a subset sum of 11 VOCs (which excluded the 
three most dominant VOCs: ethanol, acetone and 2-propanol). A task-exposure matrix 
(TEM) was created that included parameter estimates (β) for TVOC14 and TVOC11 for 
each of the 14 CDAs. The parameter estimates for the 14 CDAs were assigned to 
participants in the epidemiologic study if they reported performing a particular CDA in their 
questionnaire responses. Frequency-weighted TVOC14 and TVOC11 exposures were 
estimated for each participant using weekly frequency fractions reported in the questionnaire 
(0/7, 2/7, and 5.5/7 day/week), and the parameter estimates obtained from the predictive 
models. The equation used to calculate the two TVOC exposures is shown below:
TVOC14 or TVOV11 Exposure = e
Intercept + β1 × PA1 × F1 +⋯ + βn × PAn × Fn
where β1 … βn are parameter estimates (i.e., coefficients) for 14 CDAs obtained in the linear 
mixed effect models using log-transformed TVOC14 or TVOC11 measurements, PA1 … 
PAn are 14 CDAs, and F1 … Fn are weekly frequency fractions for each product application.
2.2.4. Hierarchical clustering—Hierarchical clustering with Ward’s minimum 
variance method (Ward and Joe, 1963) was applied to systematically group participants with 
similar patterns of the 27 respiratory health variables and frequency scores of 14 product 
applications (i.e., input variables), separately. Input variables were not normalized or scaled 
because all product application variables were on the same scale and had similar ranges, 
while the asthma health variable were all indicator variables with values of 0/1, with the 
exception of three indicator variables with values 0, 1, or 2. The number of clusters were 
determined using scree plots and dendrograms. For resulting asthma health clusters (HCs), 
the proportion of workers with physician-diagnosed asthma, positive allergic status, BHR-
related symptoms, COPD, emphysema, their demographics and smoking status and average 
asthma scores were calculated. For exposure clusters (ECs), distributions of frequency-
weighted TVOC exposures were also calculated.
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Word clouds were used to visualize the complex information of resulting clusters. For 
participants in each cluster, a text file was created using the positive responses to the input 
variables. For example, if Participant 1 in HC-1 had a positive response to Question 1 
“wheezing or whistling”, then the data cell of Question 1 (column) and Participant 1 (row) 
would be filled as “wheezing or whistling” (i.e., positive responses would be replaced by 
keywords from their corresponding questions) in the text file of HC-1. A list of keywords 
and their frequencies for each cluster was generated, and then a word cloud was created 
based on the list. The size of words in the cloud depended on their frequencies (i.e., larger 
words indicating higher frequencies). We labelled the word clouds using the most frequently 
highlighted keywords to represent the underlying characteristic of the clusters (HCs), which 
include complex combination/pattern of variables. In addition to 14 input variables, the 
frequencies of job and facility were also included in the text files of ECs, and presented in 
word clouds.
2.2.5. Multinomial logistic regression—The associations of HCs with exposure 
variables including individual product applications, and ECs (one variable with multiple 
categories) were separately evaluated using multinomial logistic regression that models 
nominal dependent variables (Engel, 1988). All models were adjusted for age, gender, 
education, smoking status and allergic status, and incorporated sampling weights to adjust 
for potential selection and non-participation bias (Caridi et al., 2019). The goodness-of-fit of 
the model was evaluated using max-rescaled R2 (Nagelkerke, 1991; Shtatland et al., 2002). 
The HC and EC with the least positive responses to symptoms and CDAs, respectively, were 
assigned as reference groups. The individual product applications were indicator variables 
(yes versus no).
Hierarchical clustering was conducted using JMP version 12 software (SAS Institute Inc., 
Cary, NC). Multinomial logistic regression and descriptive analyses were conducted using 
SAS version 9.4 software (SAS Institute Inc., Cary, NC). The word clouds were generated in 
R 3.3.1 using the “ggplot2”, “tm” and “wordcloud” packages (Feinerer and Hornik, 2017; 
Fellows, 2014; R Core Team, 2016; Wickham, 2009).
3. Results
3.1. Asthma health clusters (HCs)
The hierarchical clustering identified five HCs for the 12-month asthma symptoms/care. The 
distributions of asthma symptoms/care variables, composite health outcomes, and other 
variables among five identified HCs are shown in Table 1. The clusters were labelled based 
on their prevailing symptom(s). All participants in HC-1 (n=885) had no asthma symptoms 
in the last 12 months (except one participant who had missed workdays due to asthma; this 
participant had physician-diagnosed asthma but no asthma attacks in the last 12 months; to 
avoid confusion, this observation was not shown in the word cloud). HC-1 also had a 0 for 
average asthma scores and across almost all variables used in clustering, and the smallest 
fractions of participants with BHR-related symptoms, allergies, and emphysema among all 
HCs. This cluster was labelled “no symptoms”. In HC-2 (n=640), participants had a lower 
average asthma score than the overall average of 0.48, and also has the lowest fraction of 
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participants with the classic asthma symptoms such as wheeze, SOB and chest tightness 
excluding HC-1. About one-third and more than half of participants had BHR-related 
symptoms and allergies, respectively, and a larger fraction of this cluster reported cough and 
phlegm symptoms compared to HC-3. Additionally, HC-2 had the smallest fraction of 
participants who had COPD as well as the lowest fraction of physician diagnosed asthma 
excluding HC-1. This cluster was labelled “winter cough/phlegm”. In HC-3 (n=357), more 
than half of participants had average asthma scores ≥1. About 45% and 70% of participants 
had BHR-related symptoms and allergies, respectively. HC-3 also had a higher fraction of 
participants with the classic asthma symptoms and physician diagnosed asthma compared to 
HC-2, but a smaller fraction for medication or urgent care use. This cluster was labelled 
“mild asthma symptoms”. HC-4 (n=63) had the highest average asthma score, and the 
largest fractions for BHR-related symptoms, classic asthma symptoms of wheeze, SOB and 
chest tightness, and emphysema among all HCs. HC-4 also had the highest percentages of 
former/current smokers (> 30%). With only 31% physician-diagnosed asthma, and smaller 
fraction of participants seeking medical attention compared to HC-5, this cluster likely 
represents “undiagnosed or untreated asthma” and was labelled as such. HC-5 (n=85) had 
the second highest average asthma score, but the largest fractions for allergies, physician-
diagnosed asthma, COPD, and exacerbations as indicated by the need for a variety of asthma 
treatments. This cluster was labelled “asthma attacks/exacerbations’. Note, unlike 
conventional approaches which may use a specific set of variables to define severity, in this 
data-driven approach, symptoms may be present in all clusters but in different proportions 
and in different combinations with other symptoms. Thus HCs are labelled (given meaning) 
based on prevailing symptoms, and cannot be defined by any set of specific variables as in 
the conventional approach.
3.2. Exposure clusters (ECs)
The distributions of product application variables, frequency-weighted TVOC exposures, 
job, and facility among five identified ECs are shown in Table 2. In EC-1 (n=630), 66.5% of 
the participants were nursing assistants, and 59.7% of the participants worked in nursing 
homes. The fraction of participants in EC-1 reporting positive responses to 14 product 
application variables was 0 for all except 3.17% for low chlorine bleach and 0.32% for low 
quats. This cluster was labelled “no products”. Similar to HC results, while there were many 
overlapped product applications among ECs, EC-2 to EC-5 represented different levels and 
types of exposures and occupations. We named EC-2 to EC-5 based on the most common 
product applications in each EC as follows: “housekeeping/chlorine” in EC-2, “patient care” 
in EC-3, “general cleaning/laboratory” in EC-4, and “disinfection products” in EC-5.
In EC-2 (n=382), the most common product applications were high chlorine bleach (59.9%), 
high glass cleaners (35.1%), and high detergents (33.2%). More than 65% of the participants 
were environmental service workers or housekeepers. While EC-2 had the lowest means and 
medians of frequency-weighted scores for both TVOV14 and TVOC11 among all ECs 
(except EC-1), it had the highest fraction of participants using chlorine bleach; TVOCs do 
not reflect chlorine bleach exposures. In EC-3 (n=500), both high and low skin-wipes (more 
than 40%) and aerosolized medications (more than 25%), and low alcohols (28.2%) were the 
most common product applications. Licensed practical nurses or licensed vocational nurses, 
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and registered nurses accounted for more than 70% of the total EC-3 participants. 
Additionally, 51 out of 75 respiratory therapists or respiratory technicians were included in 
EC-3. In EC-4 (n=368), high alcohols (67.9%) and chlorine bleach (36.4%) were the most 
common product applications. In fact, other product applications were reported in small 
number of the participants in EC-4. Nursing assistants and lab technicians accounted for 
about 60% of the participants. The last EC, EC-5 (n=150), was the most “exposed” group. 
More than half of the participants in EC-5 used high alcohols and high-level disinfectants, 
and more than 40% used high chlorine bleach and enzymes. About 50% of the participants 
in EC-5 were nursing assistants, licensed practical nurses or licensed vocational nurses, and 
central supply workers. Not surprisingly, EC-5 had the highest means and medians of 
frequency-weighted scores for TVOC14 and TVOC11 among all ECs. Extremely high 
values of TVOC exposures were observed in upper percentiles (e.g., the 95th percentile). 
EC-5 also had the highest percentage of the participants working in hospitals (72.7%).
3.3. Associations between HCs and exposures (individual product applications and ECs)
Using “no symptoms” cluster (HC-1) as the reference group, the effects of individual 
product applications (i.e., one product application in one model) on HCs are shown in Fig. 1 
and Table A1. Six out of 14 product applications had statistically significant positive 
associations with at least one HC. The use of alcohols to sterilize medical instruments or 
clean and disinfect fixed-surface equipment or instruments was associated with “mild 
asthma symptoms”, and “asthma attacks/exacerbations” clusters. The use of chlorine bleach 
to sterilize medical instruments or clean and disinfect fixed-surface equipment or 
instruments was associated with “mild asthma symptoms”, “undiagnosed/untreated asthma”, 
and “asthma attacks/exacerbations” clusters. The use of enzymes to clean medical 
instruments or clean and disinfect fixed-surface equipment or instruments was associated 
with “undiagnosed/untreated asthma”, and “asthma attacks/exacerbations” clusters. The use 
of detergents to clean and disinfect fixed-surface equipment or instruments was associated 
with “undiagnosed/untreated asthma” cluster. Skin-wipes for use on patients was associated 
with “mild asthma symptoms”, and “asthma attacks/exacerbations” clusters. Administering 
aerosolized medications was associated with “asthma attacks/exacerbations” cluster.
Using “no products” cluster (EC-1) as the reference group, the effects of ECs for product 
applications on HCs are shown in Fig. 2 and Table A2. Except for the “winter cough/
phlegm” cluster (HC-2), the other HCs showed significant associations with different ECs. 
The “housekeeping/chlorine” cluster was associated with “undiagnosed/ untreated asthma” 
cluster (OR=3.11, 95% CI=1.46–6.63, p-value=0.003) and “asthma attacks/exacerbations” 
cluster (OR=2.71, 95% CI =1.25–5.86, p-value=0.011). The “patient care” cluster was 
associated with “asthma attacks/exacerbations” cluster (OR=2.34, 95% CI=1.16–4.72, p-
value=0.018). The “general cleaning/laboratory” cluster was associated with “asthma 
attacks/exacerbations” cluster (OR=2.35, 95% CI=1.07–5.13, p-value=0.033). The 
“disinfection products” cluster was associated with “mild asthma symptoms” cluster 
(OR=1.81, 95% CI=1.09–2.99, p-value=0.021) and “undiagnosed/untreated asthma” cluster 
(OR=3.42, 95% CI=1.24–9.39, p-value=0.017).
Su et al. Page 8
Int J Hyg Environ Health. Author manuscript; available in PMC 2020 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
For covariates (Table A2), allergic status had significant associations with all HCs, 
especially the “undiagnosed/untreated asthma” cluster (OR=9.40, 95% CI=4.54–19.4, p-
value < 0.001) and “asthma attacks/exacerbations” cluster (OR=12.7, 95% CI=6.05–26.7, p-
value < 0.001). Comparing with non-smokers, former and current smokers were 
significantly associated with the “mild asthma symptoms” cluster (OR=1.66, 95% CI=1.08–
2.57, p-value=0.021 for former smokers) and “undiagnosed/untreated asthma” cluster 
(OR=3.05, 95% CI=1.37–6.76, p-value=0.006 for former smokers; OR=3.58, 95% CI=1.36–
9.37, p-value=0.010 for current smokers).
4. Discussion
4.1. Asthma symptom/care grouping
In occupational epidemiologic studies, asthma is often defined as a dichotomous outcome; 
however, it likely occurs along a continuous spectrum with varying degree of severity, 
phenotypes and subtypes (Deliu et al., 2016; Pekkanen et al., 2005). Using hierarchical 
clustering to group participants with similar profiles of asthma-related health, we identified 
five clusters that reflected unique symptom patterns and different predominant 
characteristics. HC-1 included participants with no symptoms. HC-2 had low prevalence of 
lower respiratory symptoms, but had high prevalence of cough and phlegm production in the 
winter, and the highest proportion of those with no asthma and no allergies (except for 
HC-1). HC-3 had moderate prevalence of lower respiratory symptoms including cough and 
phlegm production, and likely represents mild asthma symptoms. HC-4 had the highest 
proportions of participants with respiratory symptoms, but moderate use of asthma 
medications and physician diagnosed asthma, and low proportion of urgent asthma 
treatment; this cluster likely represents undiagnosed/untreated asthma. Participants in HC-5 
experienced more symptoms related to asthma attacks and exacerbation and use of urgent 
treatments and likely represents workers with asthma exacerbations. HC-4 and HC-5 
represent workers at a more advanced stage of asthma than workers in HC-2 and HC3.
BHR-related symptoms and positive allergic status showed increasing trends in prevalence 
across HC-2 to HC-5; HC-2 to HC-4 were dominated by participants with allergies but no 
physician-diagnosed asthma, while HC-5 was predominantly participants with allergies and 
physician-diagnosed asthma. BHR-related symptoms and positive allergic status was 
common among cleaners with respiratory symptoms. Moreover, a recent review has reported 
co-morbidity of asthma and COPD especially after prolonged exposure or chronic asthma, 
which was observed in HC-4 and HC-5, clusters with the highest severity of asthma (Gibson 
and McDonald, 2015). Le Moual et al. (2005) defined asthma severity using a 7-grade (0–7) 
clinical score based on questions on frequency of asthma attacks, asthma symptoms and 
hospitalization and categorized the score to reflect mild or severe asthma. They observed 
significant associations between several classes of asthmagens including cleaning agents and 
severe asthma but not mild asthma among subjects with adult onset asthma. Severe asthma 
may be associated with different mechanism and phenotypes than mild asthma (Wenzel et 
al., 2017). Clustering may help in focusing prevention efforts among those classified with 
having severe asthma to avoid disability in the future.
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Several approaches have been used to explore patterns of asthma symptoms. A recent review 
summarized various grouping approaches utilized to characterize asthma subtypes (Deliu et 
al., 2016). The authors reviewed 41 asthma studies (23 studies recruited adult populations), 
and classified the grouping methods into two categories: PCA/factor analysis and mode-free 
approaches (e.g., hierarchical clustering with Ward’s method). Additionally, Deliu et al. 
(2016) discussed a third approach to grouping model-based approaches (i.e., machine 
learning approaches) that were reviewed in another paper (Howard et al., 2015). While the 
identified asthma subtypes were based on data-driven approaches and needed to be 
interpreted cautiously (especially for clinical use), the asthma subtyping is still beneficial for 
hypothesis-generating research.
For the overall study population without clustering, positive allergic status was common 
(50.9%); participants with allergies had a higher risk of asthma (p-value < 0.0001; tested 
using chi-square test). While a literature review found equivocal evidence for the association 
of atopy with cleaning-related asthma (Folletti et al., 2017), one study found atopy to be 
common among those with “not so sudden onset” irritant asthma; they note that atopy status 
is an important risk factor for this type of asthma for pre-existing as well as new-onset 
asthma (Brooks et al., 1998). Asthma among cleaning occupations is thought to be 
predominantly irritant-induced (Vizcaya et al., 2011), but allergic asthma may also manifest 
among healthcare workers due to exposure to specific sensitizers such as quaternary 
ammonium compounds (Gonzalez et al., 2014), aldehydes, or products containing amines or 
fragrances (Zock et al., 2010; Labrecque, 2012), and indoor or environmental allergens 
(Simpson et al. (2001)), including molds and damp environments (Cox-Ganser et al., 2009; 
Kurth et al., 2017; Quirce and Barranco, 2010). Thus both irritant and sensitizer asthma 
mechanisms may be important for asthma among healthcare workers. We also evaluated the 
health clusters in terms of the frequency of workers using products containing irritants, 
sensitizers, or both irritants and sensitizers, but did not observe significant differences 
among the clusters. In our analysis, the health clusters we observed are primarily 
characterized by the number and types of asthma symptoms, but we could not comment on 
asthma mechanisms or subtypes because our clustering variables were limited to symptoms 
variables only. Studies exploring asthma phenotypes and subtypes utilize different sources of 
information including questionnaires, detailed clinical observations, lung function testing 
and a variety of biomarkers of asthma mechanisms in cluster analysis (Deliu et al., 2016).
4.2. Cleaning and disinfecting product application grouping
While several individual product applications showed significant associations with HCs, 
grouping product applications was needed to avoid statistical issues and to represent mixed 
exposures (details described below). This study applied hierarchical clustering for variable/
data reduction, and the resulting ECs showed moderate variability of product applications 
within occupations (especially for nursing occupations). This finding suggested that 
compared to job titles, product applications were more appropriate indicators of 
occupational exposures in the healthcare setting. Participants in the “no products” cluster 
(EC-1) had few positive responses to product application variables that resulted in low 
estimated TVOC exposures. Nurses were the most common occupations across all ECs. 
Among five ECs, participants in the “disinfecting” cluster (EC-5) had the highest 
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concentrations for TVOC exposures. EC-5 had the higher proportions of high alcohol and 
chlorine bleach use, as well as high high-level disinfectant and enzyme use that were rarely 
used in other ECs. Compared with other ECs, EC-5 included more central supply workers. 
EC-2 had the highest proportion of use of chlorine bleach, glass cleaners, detergents and 
floor strippers, whose ingredients are not adequately captured by TVOC. Consequently, 
TVOC 14 and 11 were low for the EC-2 cluster that comprised mostly housekeepers. As 
shown in these clusters, product use is not independent, and multiple products are used 
simultaneously by workers making it difficult to evaluate their independent effects.
4.3. Associations between HCs and exposures
We found significant associations between five individual product applications and HC-5, 
the cluster with asthma exacerbations, including use of alcohol, chlorine releasing products, 
enzymatic cleaners, disinfectant wipes on patients and administration of aerosolized 
medications. HC-3 was associated with use of skin wipes, chlorine releasing products and 
alcohols, while HC-4 was associated with the use of detergents, enzymes and chlorine 
releasing products. For clustered exposures, HC-5 was associated with three ECs that 
reflected the highest exposures to alcohols, chlorine bleach, glass cleaners, detergents, use of 
skin wipes and aerosolized medications. HC-4 was significantly associated with EC-2 and 
EC-5 that comprised mixtures of housekeeping products and disinfecting products. HC-3 
was associated with EC-5, reflecting a complex mixture of exposures that occur together and 
whose independent effects cannot be evaluated. These exposures have been previously 
reported as significant predictors of various asthma outcomes, e.g., use of bleach, enzymatic 
cleaner, cleaning medical instruments, general cleaning, administration of aerosolized 
medications, and using a variety of general purpose cleaning products (Arif et al., 2009; 
Delclos et al., 2007; Dumas et al., 2017; Vizcaya et al., 2011).
4.4. Strengths and limitations
This study collected comprehensive information on respiratory health and CDAs among a 
large population of healthcare workers, and estimated the effect of mixed risk factors on 
various asthma health components. The application of this data reduction approach avoided 
raising statistical issues, including multiple testing and multi-collinearity (due to the 
correlations among CDAs), and better represented the reality of health status (multiple 
symptoms occurring together) and exposure scenario (the use of mixed chemicals). 
Moreover, word clouds were creatively used to characterize participants in the resulting 
clusters, and to provide better visualization aids for the overlapped information among 
clusters, which enables more informed decisions on preventive actions. This study 
demonstrated that the combination of hierarchical clustering and word clouds was a useful 
approach to deal with a complex dataset that included a large number of potentially 
correlated variables.
As with any study utilizing self-reported exposures and health outcomes, there is a potential 
for information bias leading to differential or non-differential exposure misclassification. We 
developed the questionnaire based on standardized instruments, and asked questions mostly 
regarding routine activities (e.g., cleaning and disinfecting tasks and product-use) or 
recurring health events (e.g., usually coughed in the winter) in a reasonable recall period 
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(i.e., last 12 months) to minimize such a bias (Althubaiti, 2016; Coughlin, 1990; Hassan, 
2005). Participation weights were applied to adjust for potential bias due to the low response 
rate of the survey (Caridi et al., 2019); studies have shown that the participation rate is a 
weak indicator of the presence of bias (Galea and Tracy, 2007; Morton et al., 2012). 
Hierarchical clustering is a data-driven approach. The characterization of the corresponding 
variables (e.g., frequencies of allergies and diagnosed asthma) showed reasonable 
consistency with input variables by cluster. It suggested that hierarchical clustering grouped 
participants meaningfully.
5. Disclaimer
The findings and conclusions in this report are those of the authors and do not necessarily 
represent the views of the National Institute for Occupational Safety and Health (NIOSH). 
Mention of any company or product does not constitute endorsement by NIOSH. In 
addition, citations to Web sites external to NIOSH do not constitute NIOSH endorsement of 
the sponsoring organizations or their programs or products. Furthermore, NIOSH is not 
responsible for the content of these Web sites. Its contents, including any opinions and/or 
conclusions are solely those of the authors.
6. Conclusions
This study examined the inherent patterns of asthma health and CDAs among healthcare 
workers in a complex survey dataset. We identified various combinations of cleaning and 
disinfecting product applications like using alcohols, bleach, high-level disinfectants, and 
enzymes to disinfect instruments and equipment as risk factors of mild (e.g., frequent 
coughing) to severe (e.g., asthma attacks) asthma health components. The unique pattern of 
symptoms that characterize the various degrees of asthma severity, and their association with 
exposure clusters can be used to better inform prevention strategies and treatment options to 
avoid disease progression to disability in the future. This study demonstrated that 
hierarchical clustering and word clouds were useful techniques for analyzing a complex 
dataset with a large number of potentially correlated variables to generate practical 
information that can be used to inform prevention.
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Appendix
Table A1
Results of the multinomial logistic regression modelsa for asthma health clusters and 
individual product applications.
Variable Health Clusters; reference = HC-1: No symptoms (n = 885)
HC-2: Winter cough/
phlegm (n = 640)
HC-3 Mild asthma 
symptoms (n =357)
HC-4: 
Undiagnosed/
untreated asthma 
(n = 63)
HC-5: Asthma 
attacks/
exacerbations (n = 
85)
n OR 95% 
CI
OR 95% 
CI
OR 95% 
CI
OR 95% 
CI
Individual 
Product 
Applications
High-level 
disinfectants
156 0.99 0.66 1.50 1.47 0.94 2.31 1.69 0.65 4.42 0.48 0.14 1.57
Alcohols 916 1.25 1.00 1.57 1.34 1.01 1.76 1.56 0.88 2.77 1.69 1.03 2.77
Chlorine 
bleach
783 1.24 0.98 1.57 1.44 1.09 1.91 3.07 1.75 5.39 1.82 1.07 3.09
Enzymes 196 1.07 0.73 1.58 1.29 0.84 1.97 2.57 1.18 5.58 2.34 1.14 4.78
Formaldehyde 38 0.99 0.46 2.11 1.32 0.55 3.20 1.31 0.30 5.75
Detergents 253 0.93 0.67 1.30 1.08 0.72 1.63 3.04 1.56 5.90 1.24 0.60 2.59
Floor wax 
stripper
117 1.16 0.72 1.87 0.78 0.42 1.46 2.26 0.76 6.76 1.11 0.28 4.33
Glass cleaners 279 1.08 0.78 1.50 0.77 0.51 1.18 1.81 0.87 3.75 0.88 0.37 2.08
Phenolics 107 1.08 0.64 1.80 1.72 0.97 3.03 0.88 0.25 3.14 1.94 0.74 5.11
Quaternary 
ammonium 
compounds
125 0.86 0.55 1.37 0.64 0.35 1.19 1.29 0.47 3.49 1.37 0.48 3.90
Skin-wipes 
used on 
patients
571 1.27 0.98 1.65 1.37 1.00 1.87 0.57 0.27 1.19 1.96 1.15 3.36
Clinical or 
medical 
laboratory 
products
244 0.98 0.68 1.41 1.50 1.00 2.26 1.32 0.58 3.04 1.22 0.57 2.62
Aerosolized 
medications
395 1.17 0.88 1.57 0.99 0.70 1.42 0.97 0.48 1.94 2.34 1.38 3.98
Dental 
products
41 1.15 0.52 2.57 1.23 0.48 3.16 1.57 0.29 8.58 1.83 0.39 8.65
OR, odds ratio; CI, confidence interval; SOB, shortness of breath.
a
Each model included one main risk factor (i.e., one product application in one model) and adjustments for age, sex, 
education, smoking and allergic status. The table shows the results for 14 individual models.
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Table A2
Results of the multinomial logistic regression modela for asthma health and cleaning and 
disinfecting clusters.
Variable Health Clusters; reference = HC-1: No symptoms (n = 885)
HC-2: Winter cough/
phlegm (n = 640)
HC-3 : Mild 
asthma symptoms 
(n = 357)
HC-4: 
Undiagnosed/
untreated asthma 
(n = 63)
HC-5 : Asthma 
attacks/
exacerbations (n = 
85)
n OR 95% 
CI
OR 95% 
CI
OR 95% 
CI
OR 95% 
CI
Age (year) 
40–49
485 0.85 0.62 1.16 0.89 0.60 1.30 1.85 0.76 4.52 1.40 0.59 3.31
50–59 697 0.84 0.62 1.13 1.03 0.72 1.48 1.52 0.62 3.71 2.78 1.29 5.97
60–83 360 0.75 0.53 1.05 0.71 0.45 1.10 0.81 0.28 2.33 1.57 0.63 3.90
18–39 488
Sex
Female 1542 1.07 0.82 1.40 1.43 1.01 2.01 4.97 2.05 12.1 2.81 1.28 6.17
Male 487
Education
 < HS 97 1.62 0.91 2.86 1.43 0.71 2.87 0.93 0.23 3.81 2.64 0.90 7.76
HS or < 
College
1319 1.52 1.17 1.97 1.22 0.90 1.66 1.50 0.76 2.95 0.95 0.55 1.64
College + 594
Smoking
Former 226 1.16 0.80 1.69 1.66 1.08 2.57 3.05 1.37 6.76 2.00 0.97 4.14
Current 113 1.13 0.68 1.90 1.43 0.80 2.56 3.58 1.36 9.37 0.79 0.20 3.07
Never 1676
Allergic 
Status
Yes 1033 2.58 2.06 3.23 4.26 3.21 5.65 9.40 4.54 19.4 12.7 6.05 26.7
No 997
EC-2:
House-
keeping/
chlorine
382 1.20 0.87 1.66 0.98 0.64 1.51 3.11 1.46 6.63 2.71 1.25 5.86
EC-3:
Patient care 500 1.21 0.88 1.65 1.26 0.86 1.85 0.66 0.27 1.63 2.34 1.16 4.72
EC-4:
General 
cleaning/
laboratory
368 1.09 0.78 1.53 1.20 0.80 1.81 1.13 0.44 2.87 2.35 1.07 5.13
EC-5:
Disinfection 
products
150 1.26 0.79 2.01 1.81 1.09 2.99 3.42 1.24 9.39 2.27 0.76 6.84
EC-1:
No products
OR, odds ratio; CI, confidence interval; SOB, shortness of breath; HS, high school.
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a
The main risk factor was exposure clusters (one variable with 5 categories) that included in one regression model with 
other covariates. The table shows the results for one model.
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Fig. 1. 
Associations* between resulting asthma health clusters and individual product applications.
HC, asthma health cluster; quats, quaternary ammonium compounds.
*Each model included one main risk factor (i.e., one product application in one model) and 
adjustments for age, sex, education, smoking and allergic status. The figure shows the results 
for 14 individual multinomial logistic regression models.
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Fig. 2. 
Associations* between resulting clusters of asthma health outcomes and clusters of product 
applications.
HC, asthma health cluster; EC, exposure cluster, CI, confidence interval.
*The main risk factor was exposure clusters (one variable with 5 categories) included in one 
model with the adjustments for age, sex, education, smoking and allergic status. The figure 
shows the results for one multinomial logistic regression model.
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